Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?
Walz
Gerd
G
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D006801:Humans; D008954:Models, Biological; D016891:Polycystic Kidney, Autosomal Dominant / Q000188:drug therapy* / Q000473:pathology*; D016559:Tacrolimus / Q000494:pharmacology; D016896:Treatment Outcome
D065092:Antidiuretic Hormone Receptor Antagonists; D016559:Tacrolimus